TATA MEMORIAL HOSPITAL

PM Modi unveiled genome sequencing data of 10,000 Indians, marking a milestone in genomics research. The Genome India Project aims to map India's genetic diversity, aiding in disease treatment and precision medicine. Data is accessible via the Indian Biological Data Centre, fostering global research and India's biotech leadership.

India achieves self-reliance in genomics with the launch of the Indian Genomic Data Set, FeED Protocols, and IBDC Portals, offering 10,000 whole genome samples for global research. This initiative, led by Dr. Jitendra Singh, aims to advance personalized healthcare, with plans to sequence 10 million genomes, positioning India as a leader in genomics and biotechnology.

Cancer treatment in India is financially draining, with CAR-T cell therapy offering hope but remaining costly at ₹25–30 lakh per patient. Efforts to reduce costs include centralized manufacturing and regulatory support. Despite its high cost, CAR-T therapy's potential for long-term remission and reduced treatment burden makes it a promising, yet inaccessible, option for many.

India's scientific temper remains imperfect 75 years after Constitution adoption; government, opposition, and celebrities promote unscientific claims and misinformation, undermining public health and scientific integrity.

Jaslok Hospital's cadaver organ donation surpasses Mumbai's 2023 record, benefiting 147 patients. Dr Bharat Shah highlights improvements in public hospital participation and ongoing efforts to bridge the demand-supply gap through awareness programs. ZTCC promotes bone and tissue donations, with Dr Astrid Lobo Gajiwala noting enhanced retrieval systems for bone donations.

Researchers emphasize the need for new generation therapeutics in precision medicine, including gene therapy, personalized medicine, immunotherapy, and advanced biologics. India is focusing on precision medicine, gene editing with CRISPR, and biologics. Collaborative ecosystems and digital health integration are accelerating innovation. Global-Bio India 2024 highlighted the shift towards biologics, India's first home-grown CAR-T cell therapy for cancer, and advanced cancer treatments. PepAI algorithm for Duchenne muscular dystrophy and repurposing of drugs were also discussed.